Since this initial discovery, TMEM106B SNPs were also found to modify disease risk in patients carrying FTD-causing C9ORF72 repeat expansions; however, the strongest association of TMEM106B SNPs with FTD risk has been repeatedly found in GRN mutation carriers [10–16]. This evidence concerns the gene GRN and frontotemporal dementia.